Houlihan Lokey Co-Chairman Sells 40,000 Converted Shares on 08/27/2025
Rhea-AI Filing Summary
Paul Eric Siegert, Co-Chairman and officer of Houlihan Lokey, Inc. (HLI), reported transactions on 08/27/2025 involving Class A and Class B common stock. The filing shows a conversion activity that resulted in the acquisition of 40,000 Class A shares and a contemporaneous sale of 40,000 Class A shares at a weighted average price of $199.95 per share, leaving the reporting person with 0 direct Class A shares after the sale. The report also discloses beneficial indirect ownership of 384,657 Class A shares held through the HL Voting Trust, with the reporting person retaining investment and dispositive control over those trust shares. The form is signed by an attorney-in-fact on behalf of Siegert and includes conversion details that Class B converts one-for-one into Class A.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider conversion and sale; represents a realized cashing of converted shares while retaining voting control via trust.
The Form 4 documents a conversion and immediate disposition of 40,000 Class A shares on 08/27/2025 at a weighted average sale price of $199.95. Such transactions are common following conversion events tied to dual-class structures and may reflect liquidity-taking rather than a change in strategic control, particularly because the reporting person continues to hold significant indirect ownership (384,657 shares) through the HL Voting Trust. For investors, the key factual points are the number of shares converted and sold, the weighted average sale price, and the retained indirect stake via the voting trust.
TL;DR: Governance implications are limited; reporting person preserves investment and dispositive power via a voting trust.
The filing clarifies that Class B shares convert one-for-one to Class A and that the reporting person retains investment control over shares in the HL Voting Trust. This preserves governance influence despite the reported sale. The form does not show any change in beneficial control of the company beyond the disclosed sale and continued trust holdings. No new agreements, pledges, or transfers altering control are reported.